Compounds > cycloheximide
Page last updated: 2024-08-17

cycloheximide and probucol

cycloheximide has been researched along with probucol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Hara, S; Kita, T; Nagano, Y; Sasada, M1
Phillips, MC; Rothblat, GH; Sakr, SW; Stoudt, GW; Williams, DL1
Hirano, K; Ikegami, C; Koseki, M; Maruyama, T; Masuda, D; Matsuura, F; Nakagawa-Toyama, Y; Shimomura, I; Tsujii, K; Ueda, Y; Yamashita, S; Zhang, Z1
Argon, Y; Falk, MJ; Felix, CA; Gasser, DL; Kwon, YJ; Licata, J; Marty, E; Ostrovsky, J; Peng, M; Polyak, E; Thomas, J; Tsukikawa, M; Xiao, R; Zhang, Z1

Other Studies

6 other study(ies) available for cycloheximide and probucol

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Probucol pretreatment enhances the chemotaxis of mouse peritoneal macrophages.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1992, Volume: 12, Issue:5

    Topics: Animals; Chemotactic Factors; Chemotaxis; Complement C5a; Cycloheximide; Lipoproteins, LDL; Macrophages; Peritoneal Cavity; Probucol; Rats

1992
Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP.
    Biochimica et biophysica acta, 1999, Apr-19, Volume: 1438, Issue:1

    Topics: Animals; Apolipoprotein A-I; Cell Line; Cholesterol; Cyclic AMP; Cycloheximide; Macrophages, Peritoneal; Membrane Proteins; Mice; Probucol; Thionucleotides; Trypsin

1999
Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:11

    Topics: Adult; Animals; Anticholesteremic Agents; Atherosclerosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cycloheximide; Disease Models, Animal; Gene Expression; Hepatocytes; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Probucol; Protein Synthesis Inhibitors; Rabbits; RNA, Messenger; Scavenger Receptors, Class B; Species Specificity

2005
Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease.
    Human molecular genetics, 2015, Sep-01, Volume: 24, Issue:17

    Topics: Animals; Autophagy; Cell Survival; Cycloheximide; Cytosol; Disease Models, Animal; Electron Transport; Endoplasmic Reticulum Stress; Enzyme Activation; Gene Expression Profiling; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Mitochondria; Mitochondrial Diseases; Models, Biological; Multiprotein Complexes; Phosphorylation; Probucol; Protein Biosynthesis; Ribosomal Protein S6 Kinases; Sirolimus; TOR Serine-Threonine Kinases; Transcriptome

2015